Inogen Inc

INGN Nasdaq CIK: 0001294133

Company Information

Industry Orthopedic, Prosthetic & Surgical Appliances & Supplies
SIC Code 3842
Entity Type operating
SEC Category Accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 859 WARD DRIVE, GOLETA, CA, 93111
Mailing Address 859 WARD DRIVE, GOLETA, CA, 93111
Phone 805-562-0500
Fiscal Year End 1231
EIN 000000000

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events January 12, 2026 View on SEC
4 Insider stock transaction report December 2, 2025 View on SEC
4 Insider stock transaction report December 2, 2025 View on SEC
10-Q Quarterly financial report November 6, 2025 View on SEC
8-K Current report of material events November 5, 2025 View on SEC
4 Insider stock transaction report September 3, 2025 View on SEC
4 Insider stock transaction report September 3, 2025 View on SEC
4 Insider stock transaction report September 3, 2025 View on SEC
10-Q Quarterly financial report August 8, 2025 View on SEC
3 Initial insider ownership report August 7, 2025 View on SEC

Material Events

8-K Other January 12, 2026
Medium Impact
  • Achieved overall sales growth of 2% in Q4 2025 ($82M) and 4% for the full year 2025 ($349M).
  • Expected to achieve positive Adjusted EBITDA for the full year 2025, signaling improved profitability and cost management.
View Analysis

Related Companies

Companies in the same industry (SIC: 3842)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.